Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.

Eckman MH, Wise RE, Naylor K, Arduser L, Lip GY, Kissela B, Flaherty M, Kleindorfer D, Khan F, Schauer DP, Kues J, Costea A.

Curr Med Res Opin. 2015 Apr;31(4):603-14. doi: 10.1185/03007995.2015.1019608. Epub 2015 Mar 13.

PMID:
25690491
2.

Rate modulation drugs in atrial fibrillation: what is the clinical impact?

Costea AI, Platonov PG.

J Cardiovasc Electrophysiol. 2015 Feb;26(2):142-4. doi: 10.1111/jce.12590. Epub 2015 Jan 4. No abstract available.

PMID:
25431209
3.

Integrating real-time clinical information to provide estimates of net clinical benefit of antithrombotic therapy for patients with atrial fibrillation.

Eckman MH, Wise RE, Speer B, Sullivan M, Walker N, Lip GY, Kissela B, Flaherty ML, Kleindorfer D, Khan F, Kues J, Baker P, Ireton R, Hoskins D, Harnett BM, Aguilar C, Leonard A, Prakash R, Arduser L, Costea A.

Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):680-6. doi: 10.1161/CIRCOUTCOMES.114.001163. Epub 2014 Sep 9.

PMID:
25205788
4.

Follow up for emergency department patients after intravenous contrast and risk of nephropathy.

Hassen GW, Hwang A, Liu LL, Mualim F, Sembo T, Tu TJ, Wei DH, Johnston P, Costea A, Meletiche C, Usmani S, Barber A, Jaiswal R, Kalantari H.

West J Emerg Med. 2014 May;15(3):276-81. doi: 10.5811/westjem.2013.8.17915. Epub 2014 Jan 7.

5.

The neglected lead on electrocardiogram: T wave inversion in lead aVL, nonspecific finding or a sign for left anterior descending artery lesion?

Hassen GW, Costea A, Smith T, Carrazco C, Hussein H, Soroori-Rad B, Vaidian S, Seashore J, Alderwish E, Sun W, Chen A, Simmons B, Usmani S, Kalantari H, Fernaine G.

J Emerg Med. 2014 Feb;46(2):165-70. doi: 10.1016/j.jemermed.2013.08.079. Epub 2013 Nov 25.

PMID:
24286713
6.

Cardiac-resynchronization therapy in heart failure with a narrow QRS complex.

Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J; EchoCRT Study Group.

N Engl J Med. 2013 Oct 10;369(15):1395-405. doi: 10.1056/NEJMoa1306687. Epub 2013 Sep 2.

7.

Does angiotensin-converting enzyme inhibitor use exacerbate hereditary angioedema?

Hassen GW, Tu TJ, Wei DH, Hwang A, Lamothe R, Costea A, Liu LL, Smith T, Mualim F, Johnston P, Ng JM, Usmani S, Kalantari H.

J Emerg Med. 2013 Oct;45(4):602-8. doi: 10.1016/j.jemermed.2013.05.045. Epub 2013 Jul 25.

PMID:
23890533
8.

[Epidemiologic and functional aspects of rheumatoid arthritis in patients attending the Hospital Rehabilitation Clinic in Iasi, Romania].

Costea AI, Ancuţa C, Chirieac R.

Rev Med Chir Soc Med Nat Iasi. 2011 Oct-Dec;115(4):1219-24. Romanian.

PMID:
22276473
9.

Biventricular pacing leading to coronary stent fracture.

Sanchez CE, Cilingiroglu M, Leesar MA, Costea A.

Tex Heart Inst J. 2011;38(2):208-9. No abstract available.

10.

Evolution of chronic hypertensive nephropathies treated with ACE inhibitors on patients in pre-dialysis stage.

Costea AC, Costea DO, David C, Grasa CN.

J Med Life. 2010 Apr-Jun;3(2):144-8.

PMID:
20968199
11.

Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.

Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, Shinn T, Dan D, Feldman LA, Seide H, Winston SA, Gallagher JJ, Langberg JJ, Mitchell K, Holcomb R; REPLACE Registry Investigators.

Circulation. 2010 Oct 19;122(16):1553-61. doi: 10.1161/CIRCULATIONAHA.110.976076. Epub 2010 Oct 4.

12.

[Role of ACE inhibitors in the management of arterial hypertension of hemodyalised patients].

Costea AC, Costea DO, David C, Grasa CN.

Rev Med Chir Soc Med Nat Iasi. 2010 Jan-Mar;114(1):29-33. Romanian.

PMID:
20509272
13.

Arterial hypertension management with conversion enzyme inhibitors in hemodialysis patients.

Costea AC, Costea DO, David C, Grasa CN.

J Med Life. 2010 Jan-Mar;3(1):67-9.

14.

Will imaging assist in the selection of patients with heart failure for an ICD?

Gerson MC, Abdallah M, Muth JN, Costea AI.

JACC Cardiovasc Imaging. 2010 Jan;3(1):101-10. doi: 10.1016/j.jcmg.2009.07.013. Review.

15.

Complications associated with generator replacement in response to device advisories.

Costea A, Rardon DP, Padanilam BJ, Fogel RI, Prystowsky EN.

J Cardiovasc Electrophysiol. 2008 Mar;19(3):266-9. Epub 2007 Dec 12.

PMID:
18081773
16.

[Meropenem activity against staphylococci].

Poiată A, Tuchiluş C, Costea A, Buiuc D.

Rev Med Chir Soc Med Nat Iasi. 2005 Jan-Mar;109(1):183-6. Romanian.

PMID:
16607852
17.
18.
19.

[Prevention and treatment of respiratory complications].

Serban E, Costea A.

Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit. 1982 Mar;30(3):55-6. Romanian. No abstract available.

PMID:
6814049
20.

[Value of the circumference of the arm in determination of the nutritional status of infants].

Haimovici M, Duda R, Costea A.

Rev Med Chir Soc Med Nat Iasi. 1975 Jul-Sep;79(3):373-7. Romanian. No abstract available.

PMID:
1188217
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk